FDA Is Evolving On New Chemical Entity Exclusivity
Combination drugs are becoming increasingly important in treating chronic diseases such as heart disease, stroke, cancer, diabetes and arthritis, which are some of the most common, costly and preventable of all...To view the full article, register now.
Already a subscriber? Click here to view full article